Vasopressin may be useful in the treatment of systemic anaphylaxis in rabbits

Shock

Volumn 24, Issue 3, 2005, Pages 264-269

  Hiruta, Akiko ^a   Mitsuhata, Hiromasa ^b   Hiruta, Masahiro ^a   Horikawa, Yukari ^a   Takeuchi, Haruhiko ^a   Kawakami, Takayuki ^a   Saitoh, Jin ^a   Seo, Norimasa ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Circulatory depression; In vivo; Shock; Survival rate; Therapy

Indexed keywords

VASOPRESSIN; VASOPRESSIN V1 RECEPTOR;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHOSPASM; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RECEPTOR BINDING; FEMALE; HEMORRHAGIC SHOCK; HORSE; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RABBIT; SEPTIC SHOCK; SURVIVAL RATE; SYSTEMIC DISEASE; TREATMENT OUTCOME; VASOCONSTRICTION;

ANAPHYLAXIS; ANIMALS; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HYPOTENSION; MALE; RABBITS; SHOCK, SEPTIC; TEMPERATURE; TIME FACTORS; TREATMENT OUTCOME; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 24644469890     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000172365.96752.57     Document Type: Article

References (29)

1. Voelckel WG, Lurie KG, Lindner KH, Zielinski T, McKnite S, Krismer AC, Wenzel V: Vasopressin improves survival after cardiac arrest in hypovolemic shock. Anesth Analg 91:627-634, 2000.
2. Stadlbauer KH, Wagner-Berger HG, Raedler C, Voelckel WG, Wenzel V, Krismer AC, Klima G, Rheinberger K, Nussbaumer W, Pressmar D, Lindner KH, Königstrainer A: Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiology 98:699-704, 2003.
3. Patel BM, Chittock DR, Russell JA, Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576-582, 2002.
4. Forrest P: Vasopressin and shock. Anaesth Intensive Care 29:463-472, 2001.
5. Share L: Role of vasopressin in cardiovascular regulation. Physiol Rev 68:1248-1284, 1988.
6. Luk J, Ajaelo I, Wong V, Wong J, Chang D, Chou L, Reid IA: Role of V1 receptors in the action of vasopressin on the baroreflex control of heart rate. Am J Physiol 265:524-529, 1993.
7. Warner TD: Simultaneous perfusion of rat isolated superior mesenteric arterial and venous bed: comparison of their vasoconstrictor and vasodilator responses to agonists. Br J Pharmacol 99:427-433, 1990.
8. Abboud FM, Aylward PE, Floras JS, Gupta BN: Sensitization of aortic and cardiac baroreceptors by arginine vasopressin in mammals. J Physiol 377:251-265, 1986.
9. Patel KP, Whiteis CA, Lund DD, Schmid PG: Effects of intravenous infusions of vasopressin and angiotensin II on central and peripheral noradrenergic function in conscious rabbits. Can J Physiol Pharmacol 65:765-772, 1987.
10. Seino M, Abe K, Tsunoda K, Yoshinaga K: Interaction of vasopressin and prostaglandins through calcium ion in the renal circulation. Hypertension 7:53-58, 1985.
11. Elliott JM, West MJ, Chalmers J: Effects of vasopressin on heart rate in conscious rabbits. J Cardiovasc Pharmacol 7:6-11, 1985.
12. Schummer W, Shummer C, Wippermann J, Fuchs J: Anaphylactic shock: is vasopressin the drug of choice? Anesthesiology 101:1025-1027, 2004.
13. Williams SR, Denault AY, Pellerin M, Martineau R: Vasopressin for treatment of shock following aprotinin administration. Can J Anesth 51:169-172, 2004.
14. Barsan WG, Hedges JR, Syverud SA, Dalsey WC: A hemodynamic model for anaphylactic shock. Ann Emerg Med 14:834-839, 1985.
15. Amudur M, Mead J: Mechanics of respiration in unanesthetized guinea pigs. Am J Physiol 192:364-368, 1958.
16. Denis M, Douglas J, Casby J, Stolwijk J, Bouhuys A: On-line analog computer for dynamic lung compliance and pulmonary resistance. J Appl Physiol 26:248-252, 1969.
17. Ryckwaert F, Colson P, Andre E, Perrigault PF, Guillon G, Barberis C: Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig. Br J Anaesth 89:599-604, 2002.
18. Reilly PM, Bulkley GB: Vasoactive mediators and splanchnic perfusion. Crit Care Med 21:55-68, 1993.
19. Jacobsen J, Johnsen CR, Skov PS, Warberg J, Knigge U, Secher NH: Cardiovascular and hormonal responses to anaphylactic shock in the pig. Clin Physiol 15:81-90, 1995.
20. Tsuneyoshi I, Yamada H, Kakihana Y: Hemodynamic and metabolic effects of low-vasopressin infusions in vasodilatory septic shock. Crit Care Med 29:487-493, 2001.
21. Jacobsen J, Sofelt S, Sheikh S, Warberg J, Secher NH: Cardiovascular and endocrine responses to haemorrhage in the pig. Acta Physiol Scand 138:167-173, 1990.
22. King KA, Courneya CA, Tang C, Wilson N, Ledsome JR: Pharmacokinetics of vasopressin and atrial natriuretic peptide in anesthetized rabbits. Endocrinology 124:77-83, 1989.
23. Fuhr W, Russo K, Weiss HR: Effect of vasopressin on myocardial capillary recruitment and coronary blood flow in the anesthetized rabbit. Can J Physiol Pharmacol 69:170-175, 1991.
24. Cowley AW Jr: Vasopressin and blood pressure regulation. Clin Physiol Biochem 6:150-162, 1988.
25. Hasome N, Mitsuhata H, Saitoh J, Takeuchi H, Shimizu R: An isoenzyme-selective inhibitor of phosphodiesterase 4 and 1, KF19514, may be useful in the treatment of systemic anaphylaxis: an in vivo study in rabbits. Shock 12:46-53, 1999.
26. Kawakami T, Mitsuhata H, Saitoh J, Takeuchi H, Hasome N, Hiruta M, Horikawa Y, Seo N: Hypotension associated with systemic aggregated anaphylaxis is not attenuated by a selective endothelin-A receptor antagonist, BQ 610, in rabbits in vivo. J Anesth 17:22-29, 2003.
27. Mitsuhata H, Saitoh J, Hasome N, Takeuchi H, Horiguchi Y, Shimizu R: Nitric oxide synthase inhibition is detrimental to cardiac function and promotes bronchospasm in anaphylaxis in rabbits. Shock 4:143-148, 1995.
28. Evora PRB, Pearson PJ, Schaff HV: Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. Chest 103:1241-1245, 1993.
29. Jin H, Yang R, Chen Y, Thornton RM, Jackson RM, Oparil S: Hemodynamic effects of arginine vasopressin in rats adapted to chronic hypoxia. J Appl Physiol 66:151-160, 1989.